g., a wide variety of virulence factor genes and the influence of environmental conditions); these studies are usually limited either by the sampling strategy applied (e.g., including a low number of isolates, species or types of infection), incomplete Selleckchem Ricolinostat virulence factor analyses, or an absence of virulence gene expression analysis. Overall, in the case of

generalist opportunistic pathogens, which do not meet all of the criteria Koch’s postulate, the link between virulence-related genes and infection is not clearly established, and this opportunistic pathogenic behavior may instead be considered to represent an adaptation to human ecology [9–11]. There is evidence that genetic clusters can correspond to ecologically distinct populations and/or host-adapted populations, even when genes that are not related to virulence are considered [9, 11–14]. In this context, in an attempt to improve the understanding of human aeromonosis, we investigated whether clinical isolates displayed specific

characteristics among a large population of Aeromonas spp. from various origins. Because the 3 main Aeromonas species recovered from human clinical infectious diseases are A. caviae A. hydrophila

Galunisertib price and A. veronii biovar sobria, we particularly focused on isolates belonging to these 3 taxa. The aim of this work was to determine the genetic characteristics, population structure and mode of evolution in a large population of aeromonads using a comparative approach that examined human, non-human animal and environmental strains. For this purpose, we developed a multilocus sequence Adenosine analysis (MLSA) scheme specific for aeromonads, representing the third MLSA scheme to be described for this genus [15, 16]. This strategy provided 4 new genes and produced new information on the mode of evolution, recombination rates and horizontal gene transfer in these species. This study, which was based on a large human clinical strain collection, provides interesting insight regarding the mode of evolution of aeromonads linked with human infection. Methods Bacterial strains A total of 195 strains of Aeromonas spp., including 62 type and reference strains, were analyzed. The distribution of the GSK461364 molecular weight origin of these strains was as follows: 115 human clinical strains, 39 non-human animal strains and 41 environmental strains (Table 1).